ExeGi Pharma has announced participation in a clinical trial funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to study the probiotic Visbiome in people living with HIV. 

READ FULL ARTICLE Curated publisher From PR Newswire